Latest MD Buyline Ratings Show Significant, Sustained Increase in User Satisfaction for Accuray Incorporated’s TomoTherapy® System

Latest MD Buyline Ratings Show Significant, Sustained Increase in User Satisfaction for Accuray Incorporated’s TomoTherapy® System

[PR Newswire] – SUNNYVALE, Calif., Feb. 11, 2014 /PRNewswire/ — Accuray Incorporated (ARAY) announced today that overall user satisfaction for its TomoTherapy® System has increased for the fifth consecutive quarter, according to the Q4 2013 MD Buyline more

View todays social media effects on ARAY

View the latest stocks trending across Twitter. Click to view dashboard

See who Accuray is hiring next, click here to view

Share this post